[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Rotigotine.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Rotigotine.]
[M03AB01, succinylcholine, Succinylcholine may increase the sedative activities of Rotigotine.]
[M01AB02, sulindac, The risk or severity of hypertension can be increased when Sulindac is combined with Rotigotine.]
[N05AL01, sulpiride, Sulpiride may increase the sedative activities of Rotigotine.]
[N03AX03, sulthiame, Sulthiame may increase the sedative activities of Rotigotine.]
[M01AX04, apazone, The risk or severity of hypertension can be increased when Rotigotine is combined with Azapropazone.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Rotigotine.]
[N05CD07, temazepam, Temazepam may increase the sedative activities of Rotigotine.]
[R03CC03, terbutaline, The risk or severity of hypertension can be increased when Terbutaline is combined with Rotigotine.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Rotigotine.]
[S01HA03, tetracaine, Tetracaine may increase the sedative activities of Rotigotine.]
[N05AE05, lurasidone, Lurasidone may increase the sedative activities of Rotigotine.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.]
[N04BC07, apomorphine, Apomorphine may increase the sedative activities of Rotigotine.]
[L04AX02, thalidomide, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Rotigotine.]
[R06AD03, thiethylperazine, Thiethylperazine may increase the sedative activities of Rotigotine.]
[N05CA19, thiopental, Thiopental may increase the sedative activities of Rotigotine.]
[N05AB08, thioproperazine, Thioproperazine may increase the sedative activities of Rotigotine.]
[N05AC02, thioridazine, Thioridazine may increase the sedative activities of Rotigotine.]
[N05AF04, thiothixene, Thiothixene may increase the sedative activities of Rotigotine.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Rotigotine.]
[G04BE06, moxisylyte, The risk or severity of hypertension can be increased when Rotigotine is combined with Moxisylyte.]
[N05AL03, tiapride, Tiapride may increase the sedative activities of Rotigotine.]
[B01AC05, ticlopidine, The metabolism of Rotigotine can be decreased when combined with Ticlopidine.]
[N02AX01, tilidine, Tilidine may increase the sedative activities of Rotigotine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Rotigotine.]
[M02AX02, tolazoline, Rotigotine may decrease the antihypertensive activities of Tolazoline.]
[M02AA21, tolmetin, The risk or severity of hypertension can be increased when Tolmetin is combined with Rotigotine.]
[M03BX04, tolperisone, Tolperisone may increase the sedative activities of Rotigotine.]
[N02AX02, tramadol, The risk or severity of serotonin syndrome can be increased when Rotigotine is combined with Tramadol.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the sedative activities of Rotigotine.]
[N06AX05, trazodone, The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Rotigotine.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Rotigotine.]
[C03DB02, triamterene, The risk or severity of adverse effects can be increased when Triamterene is combined with Rotigotine.]
[N05CD05, triazolam, Triazolam may increase the sedative activities of Rotigotine.]
[C03AA06, trichlormethiazide, Rotigotine may decrease the antihypertensive activities of Trichlormethiazide.]
[A03AB12, mepenzolate, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[N05AB06, trifluoperazine, Trifluoperazine may increase the sedative activities of Rotigotine.]
[N05AD02, trifluperidol, Trifluperidol may increase the sedative activities of Rotigotine.]
[N05AA05, triflupromazine, Triflupromazine may increase the sedative activities of Rotigotine.]
[N04AA01, trihexyphenidyl, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[A03AA05, trimebutine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, Alimemazine may increase the sedative activities of Rotigotine.]
[N03AC02, trimethadione, Trimethadione may increase the sedative activities of Rotigotine.]
[C02BA01, trimethaphan, Rotigotine may decrease the antihypertensive activities of Trimethaphan.]
[N06AA06, trimipramine, Trimipramine may increase the sedative activities of Rotigotine.]
[R06AC04, tripelennamine, The metabolism of Rotigotine can be decreased when combined with Tripelennamine.]
[R06AX07, triprolidine, Triprolidine may increase the sedative activities of Rotigotine.]
[A03BB01, butylscopolamine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[J01FA08, troleandomycin, The metabolism of Rotigotine can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, Vilazodone may increase the sedative activities of Rotigotine.]
[N06AX02, tryptophan, Tryptophan may increase the sedative activities of Rotigotine.]
[C09CA09, azilsartan medoxomil, Rotigotine may decrease the antihypertensive activities of Azilsartan medoxomil.]
[M03AA02, tubocurarine, Tubocurarine may increase the sedative activities of Rotigotine.]
[L02BX03, abiraterone, The metabolism of Rotigotine can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Rotigotine can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Rotigotine can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Rotigotine can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Rotigotine can be decreased when combined with Rilpivirine.]
[N03AX21, ezogabine, Ezogabine may increase the sedative activities of Rotigotine.]
[R03AC18, indacaterol, The risk or severity of hypertension can be increased when Indacaterol is combined with Rotigotine.]
[C08DA01, verapamil, The metabolism of Rotigotine can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Rotigotine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Rotigotine can be decreased when combined with Vinblastine.]
[C04AX07, vincamine, Rotigotine may decrease the antihypertensive activities of Vincamine.]
[B01AA03, warfarin, The risk or severity of adverse effects can be increased when Rotigotine is combined with Warfarin.]
[S01AA13, fusidic acid, The metabolism of Rotigotine can be decreased when combined with Fusidic acid.]
[N01AX15, xenon, The risk or severity of hypertension can be increased when Rotigotine is combined with Xenon.]
[C03BA10, xipamide, Rotigotine may decrease the antihypertensive activities of Xipamide.]
[N05AF05, zuclopenthixol, Zuclopenthixol may increase the sedative activities of Rotigotine.]
[J05AE02, indinavir, The metabolism of Rotigotine can be decreased when combined with Indinavir.]
[N03AX14, levetiracetam, Levetiracetam may increase the sedative activities of Rotigotine.]
[L01EC01, vemurafenib, The metabolism of Rotigotine can be decreased when combined with Vemurafenib.]
[L01ED01, crizotinib, The metabolism of Rotigotine can be decreased when combined with Crizotinib.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Rotigotine is combined with Ziprasidone.]
[N02BA01, aspirin, The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Rotigotine.]
[G04BD07, tolterodine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Rotigotine.]
[J02AC03, voriconazole, The metabolism of Rotigotine can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, Atracurium may increase the sedative activities of Rotigotine.]
[S01FA01, atropine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Rotigotine.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.]
[A08AA11, lorcaserin, Lorcaserin may increase the sedative activities of Rotigotine.]
[G04BD12, mirabegron, The serum concentration of Rotigotine can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Rotigotine can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Rotigotine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Rotigotine can be decreased when it is combined with Enzalutamide.]
[C01CA18, octopamine, The risk or severity of hypertension can be increased when Rotigotine is combined with Octopamine.]
[N05CA04, barbital, Barbital may increase the sedative activities of Rotigotine.]
[J05AE04, nelfinavir, The metabolism of Rotigotine can be decreased when combined with Nelfinavir.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.]
[N04BD02, rasagiline, Rasagiline may increase the sedative activities of Rotigotine.]
[C08CA13, lercanidipine, Rotigotine may decrease the antihypertensive activities of Lercanidipine.]
[A03FA09, mosapride, Mosapride may increase the sedative activities of Rotigotine.]
[N06DA02, donepezil, Donepezil may increase the sedative activities of Rotigotine.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.]
[N02CC03, zolmitriptan, The risk or severity of vasospastic reactions can be increased when Rotigotine is combined with Zolmitriptan.]
[R06AC06, thonzylamine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, The metabolism of Rotigotine can be decreased when combined with Darifenacin.]
[N01AA01, ethyl ether, Diethyl ether may increase the sedative activities of Rotigotine.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Rotigotine.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Rotigotine.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Rotigotine.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Rotigotine can be decreased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, Rotigotine may decrease the antihypertensive activities of Bendroflumethiazide.]
[L04AX06, pomalidomide, Pomalidomide may increase the sedative activities of Rotigotine.]
[G03XC05, ospemifene, The metabolism of Rotigotine can be decreased when combined with Ospemifene.]
[N02BA10, benorilate, The risk or severity of hypertension can be increased when Rotigotine is combined with Benorilate.]
[N05AD07, benperidol, Benperidol may increase the sedative activities of Rotigotine.]
[A10BK02, canagliflozin, The risk or severity of adverse effects can be increased when Rotigotine is combined with Canagliflozin.]
[A06AX06, tegaserod, The metabolism of Rotigotine can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, Benzocaine may increase the sedative activities of Rotigotine.]
[M01AH01, celecoxib, The metabolism of Rotigotine can be decreased when combined with Celecoxib.]
[N02CC02, naratriptan, Naratriptan may increase the sedative activities of Rotigotine.]
[L04AA18, everolimus, The metabolism of Rotigotine can be decreased when combined with Everolimus.]
[N04AC01, benztropine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Rotigotine can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of hypertension can be increased when Rotigotine is combined with Benzydamine.]
[P03AX06, benzyl alcohol, Benzyl alcohol may increase the sedative activities of Rotigotine.]
[N06AX28, levomilnacipran, Levomilnacipran may increase the sedative activities of Rotigotine.]
[C08EA02, bepridil, The metabolism of Rotigotine can be decreased when combined with Bepridil.]
[C02KX05, riociguat, Rotigotine may decrease the antihypertensive activities of Riociguat.]
[C02KX04, macitentan, Rotigotine may decrease the antihypertensive activities of Macitentan.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Rotigotine.]
[N06AX26, vortioxetine, Vortioxetine may increase the sedative activities of Rotigotine.]
[N03AF04, eslicarbazepine, Eslicarbazepine may increase the sedative activities of Rotigotine.]
[J05AP05, simeprevir, The metabolism of Rotigotine can be decreased when combined with Simeprevir.]
[N03AG04, vigabatrin, Vigabatrin may increase the sedative activities of Rotigotine.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Rotigotine.]
[C01CA27, droxidopa, Rotigotine may increase the hypertensive activities of Droxidopa.]
[C07AB04, acebutolol, The metabolism of Rotigotine can be decreased when combined with Acebutolol.]
[N05CH03, tasimelteon, Tasimelteon may increase the sedative activities of Rotigotine.]
[A16AA07, metreleptin, The metabolism of Rotigotine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Rotigotine can be increased when combined with Apremilast.]
[S01ED02, betaxolol, The metabolism of Betaxolol can be decreased when combined with Rotigotine.]
[C02CC01, bethanidine, Rotigotine may decrease the antihypertensive activities of Bethanidine.]
[L04AC11, siltuximab, The metabolism of Rotigotine can be increased when combined with Siltuximab.]
[A03BA03, hyoscyamine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[B01AA07, acenocoumarol, The risk or severity of adverse effects can be increased when Rotigotine is combined with Acenocoumarol.]
[N01AX05, alfaxalone, Alfaxalone may increase the sedative activities of Rotigotine.]
[A10BK03, empagliflozin, The risk or severity of adverse effects can be increased when Rotigotine is combined with Empagliflozin.]
[R03AC19, olodaterol, The risk or severity of hypertension can be increased when Rotigotine is combined with Olodaterol.]
[D11AA01, glycopyrronium, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Rotigotine can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Rotigotine can be decreased when combined with Oritavancin.]
[N05AA04, acepromazine, Acepromazine may increase the sedative activities of Rotigotine.]
[N04AA02, biperiden, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Rotigotine.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Rotigotine.]
[B01AA01, dicumarol, The risk or severity of adverse effects can be increased when Rotigotine is combined with Dicoumarol.]
[N06AX11, mirtazapine, Rotigotine may increase the serotonergic activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Rotigotine can be increased when combined with Secukinumab.]
[L01XH03, panobinostat, The metabolism of Rotigotine can be decreased when combined with Panobinostat.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be decreased when combined with Rotigotine.]
[A03AA09, difemerine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[B01AA11, tioclomarol, The risk or severity of adverse effects can be increased when Rotigotine is combined with Tioclomarol.]
[J05AP06, asunaprevir, The metabolism of Rotigotine can be decreased when combined with Asunaprevir.]
[A07DA06, eluxadoline, The risk or severity of serotonin syndrome can be increased when Rotigotine is combined with Eluxadoline.]
[N05AX16, brexpiprazole, Brexpiprazole may increase the sedative activities of Rotigotine.]
[A04AD14, rolapitant, The metabolism of Rotigotine can be decreased when combined with Rolapitant.]
[G02CX02, flibanserin, Flibanserin may increase the sedative activities of Rotigotine.]
[N05AX15, cariprazine, Cariprazine may increase the sedative activities of Rotigotine.]
[M02AA25, aceclofenac, The risk or severity of hypertension can be increased when Rotigotine is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of hypertension can be increased when Rotigotine is combined with Acemetacin.]
[S01EC01, acetazolamide, Acetazolamide may increase the sedative activities of Rotigotine.]
[N05AB07, acetophenazine, Acetophenazine may increase the sedative activities of Rotigotine.]
[A02BC03, lansoprazole, The metabolism of Rotigotine can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Rotigotine.]
[J02AC05, isavuconazole, The metabolism of Rotigotine can be decreased when combined with Isavuconazole.]
[B01AC27, selexipag, Rotigotine may decrease the antihypertensive activities of Selexipag.]
[A03FA05, alizapride, The therapeutic efficacy of Rotigotine can be decreased when used in combination with Alizapride.]
[N05CA05, aprobarbital, Aprobarbital may increase the sedative activities of Rotigotine.]
[M01AE16, alminoprofen, The risk or severity of hypertension can be increased when Rotigotine is combined with Alminoprofen.]
[N03AX23, brivaracetam, Brivaracetam may increase the sedative activities of Rotigotine.]
[L01XX52, venetoclax, The metabolism of Rotigotine can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, Bromazepam may increase the sedative activities of Rotigotine.]
[N04BC01, bromocriptine, Bromocriptine may increase the sedative activities of Rotigotine.]
[A03AX08, alverine, Alverine may increase the sedative activities of Rotigotine.]
[R06AB01, brompheniramine, Dexbrompheniramine may increase the sedative activities of Rotigotine.]
[N06AA19, amineptin, Amineptine may increase the sedative activities of Rotigotine.]
[C08CA01, amlodipine, Rotigotine may decrease the antihypertensive activities of Amlodipine.]
[N06BX11, aniracetam, Aniracetam may increase the sedative activities of Rotigotine.]
[C03CA02, bumetanide, The risk or severity of adverse effects can be increased when Bumetanide is combined with Rotigotine.]
[N01BB01, bupivacaine, Bupivacaine may increase the sedative activities of Rotigotine.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Rotigotine.]
[N07BC01, buprenorphine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, Buspirone may increase the sedative activities of Rotigotine.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Rotigotine.]
[N02AF01, butorphanol, Butorphanol may increase the sedative activities of Rotigotine.]
[S01GX07, azelastine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Rotigotine can be decreased when combined with Rucaparib.]
[L01EF02, ribociclib, The metabolism of Rotigotine can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of hypertension can be increased when Balsalazide is combined with Rotigotine.]
[R03CC12, bambuterol, The risk or severity of hypertension can be increased when Bambuterol is combined with Rotigotine.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Rotigotine.]
[N02BF02, pregabalin, The therapeutic efficacy of Rotigotine can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, Beclamide may increase the sedative activities of Rotigotine.]
[C09AA07, benazepril, Rotigotine may decrease the antihypertensive activities of Benazepril.]
[S01HA02, benoxinate, Oxybuprocaine may increase the sedative activities of Rotigotine.]
[J01XX08, linezolid, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Rotigotine.]
[J05AE09, tipranavir, The metabolism of Rotigotine can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Rotigotine.]
[L04AB02, infliximab, The metabolism of Rotigotine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Rotigotine can be decreased when combined with Midostaurin.]
[N04BD03, safinamide, Safinamide may increase the sedative activities of Rotigotine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Rotigotine.]
[C07AB07, bisoprolol, Rotigotine may decrease the antihypertensive activities of Bisoprolol.]
[R03AC17, bitolterol, The risk or severity of hypertension can be increased when Bitolterol is combined with Rotigotine.]
[J05AG03, efavirenz, Efavirenz may increase the sedative activities of Rotigotine.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Rotigotine.]
[N04AA11, bornaprine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Nesiritide is combined with Rotigotine.]
[A03FA04, bromopride, The therapeutic efficacy of Rotigotine can be decreased when used in combination with Bromopride.]
[N05AD06, bromperidol, Bromperidol may increase the sedative activities of Rotigotine.]
[N05CD09, brotizolam, Brotizolam may increase the sedative activities of Rotigotine.]
[C04AX20, buflomedil, The risk or severity of hypertension can be increased when Rotigotine is combined with Buflomedil.]
[M01AB07, bumadizone, The risk or severity of hypertension can be increased when Rotigotine is combined with Bumadizone.]
[N05CA03, butobarbital, Butobarbital may increase the sedative activities of Rotigotine.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Rotigotine.]
[N06AA15, butriptyline, Butriptyline may increase the sedative activities of Rotigotine.]
[N05CA08, butylvinal, Vinylbital may increase the sedative activities of Rotigotine.]
[C09AA01, captopril, Rotigotine may decrease the antihypertensive activities of Captopril.]
[L02BB05, apalutamide, The metabolism of Rotigotine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, Carbamazepine may increase the sedative activities of Rotigotine.]
[A03AA03, camylofine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, Carbinoxamine may increase the sedative activities of Rotigotine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Rotigotine.]
[B02BX09, fostamatinib, The risk or severity of hypotension can be increased when Fostamatinib is combined with Rotigotine.]
[N03AX24, cannabidiol, Cannabidiol may increase the sedative activities of Rotigotine.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Rotigotine.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Rotigotine.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Rotigotine.]
[L01XX62, ivosidenib, The metabolism of Rotigotine can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Rotigotine.]
[N03AX17, stiripentol, The metabolism of Rotigotine can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Rotigotine.]
[S01GX12, cetirizine, Cetirizine may increase the sedative activities of Rotigotine.]
[N05CM04, carbromal, Carbromal may increase the sedative activities of Rotigotine.]
[N01BA04, chloroprocaine, Chloroprocaine may increase the sedative activities of Rotigotine.]
[R06AA06, chlorphenoxamine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, The risk or severity of hypertension can be increased when Rotigotine is combined with Lornoxicam.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Rotigotine.]
[R03BB08, revefenacin, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L04AA39, emapalumab, The metabolism of Rotigotine can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, The therapeutic efficacy of Rotigotine can be decreased when used in combination with Gilteritinib.]
[C09AA08, cilazapril, Rotigotine may decrease the antihypertensive activities of Cilazapril.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Rotigotine.]
[A03FA08, cinitapride, Cinitapride may increase the sedative activities of Rotigotine.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be decreased when combined with Rotigotine.]
[N06AX27, esketamine, The risk or severity of hypertension can be increased when Esketamine is combined with Rotigotine.]
[L04AA42, siponimod, The risk or severity of hypertension can be increased when Rotigotine is combined with Siponimod.]
[J01FA09, clarithromycin, The metabolism of Rotigotine can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of hypertension can be increased when Solriamfetol is combined with Rotigotine.]
[N06AX29, brexanolone, Brexanolone may increase the sedative activities of Rotigotine.]
[A03FA06, clebopride, The therapeutic efficacy of Rotigotine can be decreased when used in combination with Clebopride.]
[N05BA09, clobazam, Clobazam may increase the sedative activities of Rotigotine.]
[N05BA22, cloxazolam, Cloxazolam may increase the sedative activities of Rotigotine.]
[C09CA06, candesartan, Rotigotine may decrease the antihypertensive activities of Candesartan.]
[L04AB01, etanercept, The metabolism of Rotigotine can be increased when combined with Etanercept.]
[N05AA06, cyamemazine, Cyamemazine may increase the sedative activities of Rotigotine.]
[C03BX03, cicletanine, Rotigotine may decrease the antihypertensive activities of Cicletanine.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Rotigotine.]
[L01EJ02, fedratinib, The metabolism of Rotigotine can be decreased when combined with Fedratinib.]
[N07XX11, pitolisant, The serum concentration of Rotigotine can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Rotigotine.]
[C03AA09, cyclothiazide, Rotigotine may decrease the antihypertensive activities of Cyclothiazide.]
[G04BE04, yohimbine, Yohimbine may increase the sedative activities of Rotigotine.]
[N02CC08, lasmiditan, The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Rotigotine.]
[N03AX25, cenobamate, The serum concentration of Rotigotine can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Rotigotine can be increased when it is combined with Givosiran.]
[R06AB06, dexbrompheniramine, Dexbrompheniramine may increase the sedative activities of Rotigotine.]
[R06AB02, dexchlorpheniramine, The metabolism of Dexchlorpheniramine can be decreased when combined with Rotigotine.]
[N02AX03, dezocine, Dezocine may increase the sedative activities of Rotigotine.]
[N05CM21, lemborexant, Lemborexant may increase the sedative activities of Rotigotine.]
[N05AD10, lumateperone, Lumateperone may increase the sedative activities of Rotigotine.]
[M01AX21, diacetylrhein, The metabolism of Rotigotine can be decreased when combined with Diacerein.]
[H02CA02, osilodrostat, The metabolism of Rotigotine can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Rotigotine can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, Frovatriptan may increase the sedative activities of Rotigotine.]
[G04CB02, dutasteride, The risk or severity of hypertension can be increased when Dutasteride is combined with Rotigotine.]
[N05CC04, dichloralphenazone, Dichloralphenazone may increase the sedative activities of Rotigotine.]
[A07DA04, difenoxin, Difenoxin may increase the sedative activities of Rotigotine.]
[N02AA08, dihydrocodeine, Dihydrocodeine may increase the sedative activities of Rotigotine.]
[N02CC06, eletriptan, Eletriptan may increase the sedative activities of Rotigotine.]
[M01AH02, rofecoxib, The risk or severity of hypertension can be increased when Rofecoxib is combined with Rotigotine.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Rotigotine.]
[C01BD07, dronedarone, The metabolism of Rotigotine can be decreased when combined with Dronedarone.]
[N03AG02, dipropylacetamide, Valpromide may increase the sedative activities of Rotigotine.]
[N05BA02, chlordiazepoxide, Chlordiazepoxide may increase the sedative activities of Rotigotine.]
[C02AA06, methoserpidine, Rotigotine may decrease the antihypertensive activities of Methoserpidine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Rotigotine.]
[A03AA08, dihexyverine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Rotigotine is combined with Opicapone.]
[C01CA14, dopexamine, The risk or severity of adverse effects can be decreased when Rotigotine is combined with Dopexamine.]
[G04BD09, trospium, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[M01AC04, droxicam, The risk or severity of hypertension can be increased when Rotigotine is combined with Droxicam.]
[L01EX22, selpercatinib, The risk or severity of hypertension can be increased when Rotigotine is combined with Selpercatinib.]
[M02AA27, dexketoprofen, The risk or severity of hypertension can be increased when Rotigotine is combined with Dexketoprofen.]
[N05CM02, chlormethiazole, Clomethiazole may increase the sedative activities of Rotigotine.]
[M03BB02, chlormezanone, Chlormezanone may increase the sedative activities of Rotigotine.]
[R02AD04, dyclonine, Dyclonine may increase the sedative activities of Rotigotine.]
[C08CA17, levamlodipine, Rotigotine may decrease the antihypertensive activities of Levamlodipine.]
[P01BB01, proguanil, The metabolism of Rotigotine can be decreased when combined with Proguanil.]
[N05CD14, remimazolam, Remimazolam may increase the sedative activities of Rotigotine.]
[L04AC19, satralizumab, The serum concentration of Rotigotine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Rotigotine is combined with Oliceridine.]
[P01BA01, chloroquine, The metabolism of Rotigotine can be decreased when combined with Chloroquine.]
[C03AA04, chlorothiazide, Rotigotine may decrease the antihypertensive activities of Chlorothiazide.]
[R06AB04, chlorpheniramine, Chlorpheniramine may increase the sedative activities of Rotigotine.]
[N05AA01, chlorpromazine, Chlorpromazine may increase the sedative activities of Rotigotine.]
[N05AF03, chlorprothixene, Chlorprothixene may increase the sedative activities of Rotigotine.]
[C03BA04, chlorthalidone, Rotigotine may decrease the antihypertensive activities of Chlorthalidone.]
[M03BB03, chlorzoxazone, Chlorzoxazone may increase the sedative activities of Rotigotine.]
[A11CC05, cholecalciferol, The metabolism of Rotigotine can be decreased when combined with Cholecalciferol.]
[N05BX03, etifoxine, Etifoxine may increase the sedative activities of Rotigotine.]
[N02BA07, ethenzamide, The risk or severity of hypertension can be increased when Rotigotine is combined with Ethenzamide.]
[N06BX18, vinpocetine, Vinpocetine may increase the sedative activities of Rotigotine.]
[N05BA18, ethyl loflazepate, Ethyl loflazepate may increase the sedative activities of Rotigotine.]
[M01AB08, etodolac, The risk or severity of hypertension can be increased when Etodolac is combined with Rotigotine.]
[M02AA06, etofenamate, The risk or severity of hypertension can be increased when Rotigotine is combined with Etofenamate.]
[B06AC06, berotralstat, The metabolism of Rotigotine can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Rotigotine can be decreased when combined with Lonafarnib.]
[L01FX21, naxitamab, The risk or severity of hypertension can be increased when Rotigotine is combined with Naxitamab.]
[P03AX07, abametapir, The serum concentration of Rotigotine can be increased when it is combined with Abametapir.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Rotigotine is combined with Vericiguat.]
[M03BA05, febarbamate, Febarbamate may increase the sedative activities of Rotigotine.]
[N03AX10, felbamate, Felbamate may increase the sedative activities of Rotigotine.]
[M01AE05, fenbufen, The risk or severity of hypertension can be increased when Rotigotine is combined with Fenbufen.]
[C01CA19, fenoldopam, The risk or severity of adverse effects can be decreased when Fenoldopam is combined with Rotigotine.]
[N06BA08, fenozolone, The risk or severity of hypertension can be increased when Rotigotine is combined with Fenozolone.]
[G04CB01, finasteride, The risk or severity of hypertension can be increased when Finasteride is combined with Rotigotine.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Rotigotine.]
[N01AB05, trichloroethylene, Trichloroethylene may increase the sedative activities of Rotigotine.]
[L03AB10, peginterferon alfa-2b, The metabolism of Rotigotine can be decreased when combined with Peginterferon alfa-2b.]
[H04AA02, dasiglucagon, Rotigotine may decrease the antihypertensive activities of Dasiglucagon.]
[A02BA01, cimetidine, The metabolism of Rotigotine can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, Gabapentin may increase the sedative activities of Rotigotine.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Rotigotine.]
[L01XX73, sotorasib, The serum concentration of Rotigotine can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Rotigotine can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, Citalopram may increase the sedative activities of Rotigotine.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Rotigotine.]
[R06AA04, clemastine, Clemastine may increase the sedative activities of Rotigotine.]
[R03CC13, clenbuterol, The risk or severity of hypertension can be increased when Clenbuterol is combined with Rotigotine.]
[N06AX25, St. John's wort extract, St. John's Wort may increase the sedative activities of Rotigotine.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Rotigotine.]
[N01BB10, levobupivacaine, Levobupivacaine may increase the sedative activities of Rotigotine.]
[N06AA04, clomipramine, Clomipramine may increase the sedative activities of Rotigotine.]
[N03AE01, clonazepam, Clonazepam may increase the sedative activities of Rotigotine.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Rotigotine.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be increased when it is combined with Rotigotine.]
[N05AH06, clothiapine, Clothiapine may increase the sedative activities of Rotigotine.]
[N05BA21, clotiazepam, Clotiazepam may increase the sedative activities of Rotigotine.]
[A04AA01, ondansetron, Ondansetron may increase the sedative activities of Rotigotine.]
[A04AA02, granisetron, Granisetron may increase the sedative activities of Rotigotine.]
[N05AH02, clozapine, Clozapine may increase the sedative activities of Rotigotine.]
[N05BA13, halazepam, Halazepam may increase the sedative activities of Rotigotine.]
[H01AC08, somatrogon, The metabolism of Rotigotine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C02KB01, metyrosine, Rotigotine may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Rotigotine can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of hypertension can be increased when Rotigotine is combined with Proquazone.]
[R05DA04, codeine, Codeine may increase the sedative activities of Rotigotine.]
[M03AC05, hexafluorenium, Hexafluronium may increase the sedative activities of Rotigotine.]
[A03AB10, hexocyclium, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[N01AB07, desflurane, Desflurane may increase the sedative activities of Rotigotine.]
[A04AA03, tropisetron, Tropisetron may increase the sedative activities of Rotigotine.]
[C04AX28, ifenprodil, Ifenprodil may increase the sedative activities of Rotigotine.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Rotigotine.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of hypertension can be increased when Rotigotine is combined with Imidazole salicylate.]
[J01FA15, telithromycin, The metabolism of Rotigotine can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Rotigotine.]
[B01AC10, indobufen, The risk or severity of hypertension can be increased when Rotigotine is combined with Indobufen.]
[R06AX27, desloratadine, Desloratadine may increase the sedative activities of Rotigotine.]
[M01AH03, valdecoxib, The risk or severity of hypertension can be increased when Valdecoxib is combined with Rotigotine.]
[A03AX10, isometheptene, The risk or severity of hypertension can be increased when Rotigotine is combined with Isometheptene.]
[N02CC05, almotriptan, Almotriptan may increase the sedative activities of Rotigotine.]
[M01AH04, parecoxib, The risk or severity of hypertension can be increased when Rotigotine is combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Rotigotine can be decreased when combined with Itraconazole.]
[N05BA10, ketazolam, Ketazolam may increase the sedative activities of Rotigotine.]
[M01AA06, kebuzone, The risk or severity of hypertension can be increased when Rotigotine is combined with Kebuzone.]
[L01EA01, imatinib, The serum concentration of Rotigotine can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Rotigotine can be decreased when combined with Posaconazole.]
[C08CA09, lacidipine, Rotigotine may increase the hypotensive activities of Lacidipine.]
[N03AX09, lamotrigine, Lamotrigine may increase the sedative activities of Rotigotine.]
[S01GX02, levocabastine, Levocabastine may increase the sedative activities of Rotigotine.]
[N07BC04, lofexidine, The therapeutic efficacy of Rotigotine can be increased when used in combination with Lofexidine.]
[M01AB09, lonazolac, The risk or severity of hypertension can be increased when Rotigotine is combined with Lonazolac.]
[N05CD06, lormetazepam, Lormetazepam may increase the sedative activities of Rotigotine.]
[M02AA31, loxoprofen, The risk or severity of hypertension can be increased when Rotigotine is combined with Loxoprofen.]
[C09AA03, lisinopril, Rotigotine may decrease the antihypertensive activities of Lisinopril.]
[C08CA11, manidipine, The metabolism of Rotigotine can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, Medifoxamine may increase the sedative activities of Rotigotine.]
[A08AA09, mefenorex, The risk or severity of hypertension can be increased when Rotigotine is combined with Mefenorex.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Rotigotine.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Rotigotine.]
[N04AA03, methixene, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[R03CB02, methoxyphenamine, The risk or severity of serotonin syndrome can be increased when Rotigotine is combined with Methoxyphenamine.]
[R06AE03, cyclizine, Cyclizine may increase the sedative activities of Rotigotine.]
[N05CA10, cyclobarbital, Cyclobarbital may increase the sedative activities of Rotigotine.]
[C03DA04, eplerenone, Rotigotine may decrease the antihypertensive activities of Eplerenone.]
[N05AD03, metylperon, Melperone may increase the sedative activities of Rotigotine.]
[C03AA07, cyclopenthiazide, Rotigotine may decrease the antihypertensive activities of Cyclopenthiazide.]
[N06AX07, minaprine, Minaprine may increase the sedative activities of Rotigotine.]
[S01XA18, cyclosporine, The metabolism of Rotigotine can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, Moclobemide may increase the sedative activities of Rotigotine.]
[R06AX02, cyproheptadine, Cyproheptadine may increase the sedative activities of Rotigotine.]
[C09AA13, moexipril, Rotigotine may decrease the antihypertensive activities of Moexipril.]
[M02AA02, mofebutazone, The risk or severity of hypertension can be increased when Rotigotine is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of hypertension can be increased when Rotigotine is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Rotigotine can be decreased when combined with Conivaptan.]
[C02AC05, moxonidine, Rotigotine may decrease the antihypertensive activities of Moxonidine.]
[G04BE09, vardenafil, The risk or severity of hypotension can be increased when Vardenafil is combined with Rotigotine.]
[M01AH05, etoricoxib, The risk or severity of hypertension can be increased when Etoricoxib is combined with Rotigotine.]
[G03XA01, danazol, The metabolism of Rotigotine can be decreased when combined with Danazol.]
[M03CA01, dantrolene, Dantrolene may increase the sedative activities of Rotigotine.]
[N06BX04, deanol, Deanol may increase the sedative activities of Rotigotine.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Rotigotine.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.]
[M01AX01, nabumetone, The risk or severity of hypertension can be increased when Nabumetone is combined with Rotigotine.]
[N05BA16, nordazepam, Nordazepam may increase the sedative activities of Rotigotine.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Rotigotine.]
[N06AX06, nefazodone, Nefazodone may increase the sedative activities of Rotigotine.]
[N05CM16, niaprazine, Niaprazine may increase the sedative activities of Rotigotine.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Rotigotine.]
[N03AG06, tiagabine, Tiagabine may increase the sedative activities of Rotigotine.]
[C01CA23, theodrenaline, The risk or severity of hypertension can be increased when Rotigotine is combined with Theodrenaline.]
[M03AC11, cisatracurium, Cisatracurium may increase the sedative activities of Rotigotine.]
[C01CA05, norfenefrine, The risk or severity of hypertension can be increased when Rotigotine is combined with Norfenefrine.]
[R05DA06, normethadone, Normethadone may increase the sedative activities of Rotigotine.]
[N06AB10, escitalopram, The risk or severity of serotonin syndrome can be increased when Rotigotine is combined with Escitalopram.]
[G04BD08, solifenacin, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[A07EC03, olsalazine, The risk or severity of hypertension can be increased when Olsalazine is combined with Rotigotine.]
[N06AA01, desipramine, Desipramine may increase the sedative activities of Rotigotine.]
[H01BA02, desmopressin, The risk or severity of hypertension can be increased when Desmopressin is combined with Rotigotine.]
[C09XA02, aliskiren, Rotigotine may decrease the antihypertensive activities of Aliskiren.]
[M01AE12, oxaprozin, The risk or severity of hypertension can be increased when Oxaprozin is combined with Rotigotine.]
[N03AF02, oxcarbazepine, Oxcarbazepine may increase the sedative activities of Rotigotine.]
[S03BA01, dexamethasone, The metabolism of Rotigotine can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, Oxiracetam may increase the sedative activities of Rotigotine.]
[N04AA08, dexetimide, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Rotigotine.]
[A03AA01, oxyphencyclimine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Rotigotine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Rotigotine.]
[N06BA02, dextroamphetamine, The metabolism of Amphetamine can be decreased when combined with Rotigotine.]
[R05DA09, dextromethorphan, Dextromethorphan may increase the sedative activities of Rotigotine.]
[N03AC01, paramethadione, Paramethadione may increase the sedative activities of Rotigotine.]
[N02AC01, dextromoramide, Dextromoramide may increase the sedative activities of Rotigotine.]
[N06AB05, paroxetine, Paroxetine may increase the sedative activities of Rotigotine.]
[N07BC06, heroin, Diamorphine may increase the sedative activities of Rotigotine.]
[N05BA01, diazepam, Diazepam may increase the sedative activities of Rotigotine.]
[N03AX07, phenacemide, Phenacemide may increase the sedative activities of Rotigotine.]
[V03AH01, diazoxide, Rotigotine may decrease the antihypertensive activities of Diazoxide.]
[N03AD02, phensuximide, Phensuximide may increase the sedative activities of Rotigotine.]
[N06AA08, dibenzepin, Dibenzepin may increase the sedative activities of Rotigotine.]
[S02DA04, dibucaine, Cinchocaine may increase the sedative activities of Rotigotine.]
[S01EC02, dichlorphenamide, The risk or severity of adverse effects can be increased when Diclofenamide is combined with Rotigotine.]
[S01BC03, diclofenac, The risk or severity of hypertension can be increased when Diclofenac is combined with Rotigotine.]
[A03AA07, dicyclomine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[C02DG01, pinacidil, Rotigotine may decrease the antihypertensive activities of Pinacidil.]
[N05AD05, pipamperone, Pipamperone may increase the sedative activities of Rotigotine.]
[A03AB14, pipenzolate, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Rotigotine.]
[R03CC07, pirbuterol, The risk or severity of hypertension can be increased when Pirbuterol is combined with Rotigotine.]
[A08AA03, diethylpropion, Diethylpropion may increase the sedative activities of Rotigotine.]
[C08CA03, isradipine, The metabolism of Rotigotine can be decreased when combined with Isradipine.]
[A03AB11, poldine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, The risk or severity of hypertension can be increased when Diflunisal is combined with Rotigotine.]
[C02DB01, dihydralazine, Rotigotine may decrease the antihypertensive activities of Dihydralazine.]
[C04AE04, dihydroergocristine, Dihydroergocristine may increase the vasoconstricting activities of Rotigotine.]
[N02CA01, dihydroergotamine, Dihydroergotamine may increase the sedative activities of Rotigotine.]
[N02AA03, hydromorphone, Hydromorphone may increase the sedative activities of Rotigotine.]
[J05AE08, atazanavir, The metabolism of Rotigotine can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, Rotigotine may decrease the antihypertensive activities of Treprostinil.]
[D04AB07, pramoxine, Pramocaine may increase the sedative activities of Rotigotine.]
[C08DB01, diltiazem, The metabolism of Rotigotine can be decreased when combined with Diltiazem.]
[R06AA11, dimenhydrinate, Dimenhydrinate may increase the sedative activities of Rotigotine.]
[M03BX03, pridinol, Pridinol may increase the sedative activities of Rotigotine.]
[R06AB03, dimethindene, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[R03CC08, procaterol, The risk or severity of hypertension can be increased when Procaterol is combined with Rotigotine.]
[M02AX03, dimethyl sulfoxide, The metabolism of Rotigotine can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, Progabide may increase the sedative activities of Rotigotine.]
[N02BB04, propyphenazone, The risk or severity of hypertension can be increased when Rotigotine is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of hypertension can be increased when Rotigotine is combined with Proglumetacin.]
[R06AA02, diphenhydramine, Diphenhydramine may increase the sedative activities of Rotigotine.]
[A07DA01, diphenoxylate, Diphenoxylate may increase the sedative activities of Rotigotine.]
[N05CD10, quazepam, Quazepam may increase the sedative activities of Rotigotine.]
[C09AA06, quinapril, Rotigotine may decrease the antihypertensive activities of Quinapril.]
[B01AC07, dipyridamole, The risk or severity of adverse effects can be increased when Dipyridamole is combined with Rotigotine.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may increase the sedative activities of Rotigotine.]
[N06AA23, quinupramine, Quinupramine may increase the sedative activities of Rotigotine.]
[A03FA02, cisapride, Cisapride may increase the sedative activities of Rotigotine.]
[C09AA05, ramipril, Rotigotine may decrease the antihypertensive activities of Ramipril.]
[N05AL04, remoxipride, Remoxipride may increase the sedative activities of Rotigotine.]
[R03CC14, reproterol, The risk or severity of hypertension can be increased when Rotigotine is combined with Reproterol.]
[C01BA03, disopyramide, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.]
[S02AA12, rifamycin SV, The metabolism of Rotigotine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Rotigotine can be increased when combined with Rifapentine.]
[N07XX02, riluzole, Riluzole may increase the sedative activities of Rotigotine.]
[N05AX08, risperidone, Rotigotine may increase the hypotensive activities of Risperidone.]
[R06AE09, levocetirizine, Levocetirizine may increase the sedative activities of Rotigotine.]
[N01BB09, ropivacaine, Ropivacaine may increase the sedative activities of Rotigotine.]
[A04AD12, aprepitant, The metabolism of Rotigotine can be decreased when combined with Aprepitant.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Rotigotine.]
[G04BE08, tadalafil, Rotigotine may decrease the antihypertensive activities of Tadalafil.]
[S01BC05, ketorolac, The risk or severity of hypertension can be increased when Ketorolac is combined with Rotigotine.]
[C02KX02, ambrisentan, Rotigotine may decrease the antihypertensive activities of Ambrisentan.]
[C01EB18, ranolazine, The serum concentration of Rotigotine can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, The risk or severity of hypertension can be increased when Salsalate is combined with Rotigotine.]
[R03AC12, salmeterol, The risk or severity of hypertension can be increased when Salmeterol is combined with Rotigotine.]
[C01CA07, dobutamine, The risk or severity of hypertension can be increased when Dobutamine is combined with Rotigotine.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Rotigotine.]
[C01CA04, dopamine, The risk or severity of hypertension can be increased when Dopamine is combined with Rotigotine.]
[N06AA16, dothiepin, Dosulepin may increase the sedative activities of Rotigotine.]
[R07AB01, doxapram, The risk or severity of hypertension can be increased when Doxapram is combined with Rotigotine.]
[N06AA12, doxepin, Doxepin may increase the sedative activities of Rotigotine.]
[L01DB01, doxorubicin, The metabolism of Rotigotine can be decreased when combined with Doxorubicin.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.]
[N06AB06, sertraline, Sertraline may increase the sedative activities of Rotigotine.]
[N01AB08, sevoflurane, Sevoflurane may increase the sedative activities of Rotigotine.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.]
[A08AA10, sibutramine, Sibutramine may increase the sedative activities of Rotigotine.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Rotigotine.]
[C09AA11, spirapril, Rotigotine may decrease the antihypertensive activities of Spirapril.]
[N05AL02, sultopride, Sultopride may increase the sedative activities of Rotigotine.]
[N02CC01, sumatriptan, Sumatriptan may increase the sedative activities of Rotigotine.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Rotigotine.]
[M01AC02, tenoxicam, The risk or severity of hypertension can be increased when Tenoxicam is combined with Rotigotine.]
[G04CA03, terazosin, Rotigotine may decrease the antihypertensive activities of Terazosin.]
[D01BA02, terbinafine, The metabolism of Rotigotine can be decreased when combined with Terbinafine.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Rotigotine.]
[S01GA02, tetrahydrozoline, The risk or severity of hypertension can be increased when Rotigotine is combined with Tetryzoline.]
[M03BX07, tetrazepam, Tetrazepam may increase the sedative activities of Rotigotine.]
[M03BX05, thiocolchicoside, Thiocolchicoside may increase the sedative activities of Rotigotine.]
[N05AB05, thiopropazate, Thiopropazate may increase the sedative activities of Rotigotine.]
[G04BD01, emepronium, Emepronium may increase the sedative activities of Rotigotine.]
[N06AX14, tianeptine, Tianeptine may increase the sedative activities of Rotigotine.]
[C09AA02, enalapril, Rotigotine may decrease the antihypertensive activities of Enalapril.]
[N05BA23, tofisopam, Tofisopam may increase the sedative activities of Rotigotine.]
[M01AG02, tolfenamic acid, The risk or severity of hypertension can be increased when Rotigotine is combined with Tolfenamic acid.]
[N06AG03, toloxatone, Toloxatone may increase the sedative activities of Rotigotine.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Rotigotine.]
[N03AX11, topiramate, Topiramate may increase the sedative activities of Rotigotine.]
[C03CA04, torsemide, Rotigotine may decrease the antihypertensive activities of Torasemide.]
[R01AA09, tramazoline, The risk or severity of hypertension can be increased when Rotigotine is combined with Tramazoline.]
[C09AA10, trandolapril, Rotigotine may decrease the antihypertensive activities of Trandolapril.]
[N05CD11, triazulenone, Loprazolam may increase the sedative activities of Rotigotine.]
[N05CC01, chloral hydrate, Chloral hydrate may increase the sedative activities of Rotigotine.]
[N05CM07, triclofos, Triclofos may increase the sedative activities of Rotigotine.]
[A03AB08, tridihexethyl, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, Trimethobenzamide may increase the sedative activities of Rotigotine.]
[N04AA12, tropatepine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[R03CC11, tulobuterol, The risk or severity of hypertension can be increased when Rotigotine is combined with Tulobuterol.]
[N01AB04, enflurane, Enflurane may increase the sedative activities of Rotigotine.]
[C02CA06, urapidil, Urapidil may increase the sedative activities of Rotigotine.]
[N05AL06, veralipride, Veralipride may increase the sedative activities of Rotigotine.]
[L01CA04, vinorelbine, The metabolism of Rotigotine can be decreased when combined with Vinorelbine.]
[S01FB02, ephedrine, The risk or severity of hypertension can be increased when Ephedrine is combined with Rotigotine.]
[S01GX10, epinastine, Epinastine may increase the sedative activities of Rotigotine.]
[N06AX16, venlafaxine, The risk or severity of serotonin syndrome can be increased when Rotigotine is combined with Venlafaxine.]
[C01CX07, xamoterol, The risk or severity of hypertension can be increased when Rotigotine is combined with Xamoterol.]
[S01GA03, xylometazoline, The risk or severity of hypertension can be increased when Rotigotine is combined with Xylometazoline.]
[C08CA12, mepirodipine, The metabolism of Rotigotine can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The risk or severity of hypertension can be increased when Epinephrine is combined with Rotigotine.]
[C09AA15, zofenopril, Rotigotine may decrease the antihypertensive activities of Zofenopril.]
[N05CF02, zolpidem, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[M01AB04, zomepirac, The risk or severity of hypertension can be increased when Zomepirac is combined with Rotigotine.]
[N03AX15, zonisamide, Zonisamide may increase the sedative activities of Rotigotine.]
[N05CF01, zopiclone, Zopiclone may increase the sedative activities of Rotigotine.]
[N05AX11, zotepine, Zotepine may increase the sedative activities of Rotigotine.]
[C02AC02, guanfacine, Guanfacine may increase the sedative activities of Rotigotine.]
[B01AC11, iloprost, The risk or severity of adverse effects can be increased when Iloprost is combined with Rotigotine.]
[C01BG01, moricizine, Moricizine may increase the sedative activities of Rotigotine.]
[G02AB03, ergonovine, Ergometrine may increase the sedative activities of Rotigotine.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may increase the sedative activities of Rotigotine.]
[N02CA02, ergotamine, Ergotamine may increase the sedative activities of Rotigotine.]
[N03AG01, valproic acid, Valproic acid may increase the sedative activities of Rotigotine.]
[S01AA17, erythromycin, The metabolism of Rotigotine can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, Estazolam may increase the sedative activities of Rotigotine.]
[H05BX01, cinacalcet, The metabolism of Rotigotine can be decreased when combined with Cinacalcet.]
[J04AK02, ethambutol, The metabolism of Rotigotine can be decreased when combined with Ethambutol.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Rotigotine.]
[C01CA15, gepefrine, The risk or severity of serotonin syndrome can be increased when Rotigotine is combined with Gepefrine.]
[N05CM08, ethchlorvynol, Ethchlorvynol may increase the sedative activities of Rotigotine.]
[V03AF05, amifostine, The risk or severity of adverse effects can be increased when Amifostine is combined with Rotigotine.]
[N04AA05, profenamine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, Ethosuximide may increase the sedative activities of Rotigotine.]
[N03AB01, ethotoin, Ethotoin may increase the sedative activities of Rotigotine.]
[M01AC06, meloxicam, The risk or severity of hypertension can be increased when Meloxicam is combined with Rotigotine.]
[S01XA06, ethylmorphine, Ethylmorphine may increase the sedative activities of Rotigotine.]
[C01CA01, etilefrine, The risk or severity of hypertension can be increased when Rotigotine is combined with Etilefrine.]
[N01AX07, etomidate, Etomidate may increase the sedative activities of Rotigotine.]
[N05AE03, sertindole, Sertindole may increase the sedative activities of Rotigotine.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Rotigotine.]
[R06AX12, terfenadine, The metabolism of Rotigotine can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The risk or severity of adverse effects can be increased when Bupropion is combined with Rotigotine.]
[N06AB08, fluvoxamine, Fluvoxamine may increase the sedative activities of Rotigotine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Rotigotine.]
[C08CA02, felodipine, The metabolism of Rotigotine can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The risk or severity of serotonin syndrome can be increased when Rotigotine is combined with Fenfluramine.]
[M01AE04, fenoprofen, The risk or severity of hypertension can be increased when Fenoprofen is combined with Rotigotine.]
[R03CC04, fenoterol, The risk or severity of hypertension can be increased when Fenoterol is combined with Rotigotine.]
[N02AB03, fentanyl, Fentanyl may increase the sedative activities of Rotigotine.]
[R03CC02, albuterol, The risk or severity of hypertension can be increased when Salbutamol is combined with Rotigotine.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Rotigotine.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Rotigotine.]
[G04BD02, flavoxate, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Rotigotine.]
[N02BG04, floctafenine, The risk or severity of hypertension can be increased when Rotigotine is combined with Floctafenine.]
[J02AC01, fluconazole, The metabolism of Rotigotine can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, Flunarizine may increase the sedative activities of Rotigotine.]
[N05CD03, flunitrazepam, Flunitrazepam may increase the sedative activities of Rotigotine.]
[N06AA14, melitracen, Melitracen may increase the sedative activities of Rotigotine.]
[V03AZ01, ethanol, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[N06AB03, fluoxetine, The serum concentration of Rotigotine can be increased when it is combined with Fluoxetine.]
[N05AF01, flupenthixol, The therapeutic efficacy of Rotigotine can be decreased when used in combination with Flupentixol.]
[N05AB02, fluphenazine, Fluphenazine may increase the sedative activities of Rotigotine.]
[N05CD01, flurazepam, Flurazepam may increase the sedative activities of Rotigotine.]
[S01BC04, flurbiprofen, The risk or severity of hypertension can be increased when Flurbiprofen is combined with Rotigotine.]
[N05AG01, fluspirilene, Fluspirilene may increase the sedative activities of Rotigotine.]
[N06BX17, adrafinil, The risk or severity of hypertension can be increased when Rotigotine is combined with Adrafinil.]
[M03AA01, alcuronium, Alcuronium may increase the sedative activities of Rotigotine.]
[G01AX06, furazolidone, Furazolidone may increase the sedative activities of Rotigotine.]
[J05AE10, darunavir, The metabolism of Rotigotine can be decreased when combined with Darunavir.]
[C03CA01, furosemide, Rotigotine may decrease the antihypertensive activities of Furosemide.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Rotigotine is combined with Eszopiclone.]
[N05AL05, amisulpride, Amisulpride may increase the sedative activities of Rotigotine.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Rotigotine.]
[M03AC02, gallamine, Gallamine may increase the sedative activities of Rotigotine.]
[N03AA04, barbexaclone, Barbexaclone may increase the sedative activities of Rotigotine.]
[N06AX08, bifemelane, Bifemelane may increase the sedative activities of Rotigotine.]
[N04BC06, cabergoline, Cabergoline may increase the sedative activities of Rotigotine.]
[N03AD03, methsuximide, Methsuximide may increase the sedative activities of Rotigotine.]
[N01AH02, alfentanil, Alfentanil may increase the sedative activities of Rotigotine.]
[N05CM18, dexmedetomidine, Dexmedetomidine may increase the sedative activities of Rotigotine.]
[N05CE01, glutethimide, Glutethimide may increase the sedative activities of Rotigotine.]
[C05AE01, nitroglycerin, Rotigotine may decrease the antihypertensive activities of Nitroglycerin.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Rotigotine.]
[C07AB09, esmolol, The metabolism of Esmolol can be decreased when combined with Rotigotine.]
[B01AA12, fluindione, The risk or severity of adverse effects can be increased when Rotigotine is combined with Fluindione.]
[C09AA09, fosinopril, Rotigotine may decrease the antihypertensive activities of Fosinopril.]
[S01EX01, guanethidine, Rotigotine may decrease the antihypertensive activities of Guanethidine.]
[P01BX01, halofantrine, The metabolism of Rotigotine can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Rotigotine.]
[N01AB01, halothane, Halothane may increase the sedative activities of Rotigotine.]
[N05AH04, quetiapine, Quetiapine may increase the sedative activities of Rotigotine.]
[N02CX03, iprazochrome, Iprazochrome may increase the sedative activities of Rotigotine.]
[N05CA21, allobarbital, Allobarbital may increase the sedative activities of Rotigotine.]
[C09CA01, losartan, Rotigotine may decrease the antihypertensive activities of Losartan.]
[A07EC02, mesalamine, The risk or severity of hypertension can be increased when Mesalazine is combined with Rotigotine.]
[N05CA16, hexobarbital, Hexobarbital may increase the sedative activities of Rotigotine.]
[R03CC05, hexoprenaline, The risk or severity of hypertension can be increased when Rotigotine is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Rotigotine.]
[C08CA10, nilvadipine, The metabolism of Rotigotine can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of hypertension can be increased when Nimesulide is combined with Rotigotine.]
[C09AA04, perindopril, Rotigotine may decrease the antihypertensive activities of Perindopril.]
[C02DB02, hydralazine, Rotigotine may decrease the antihypertensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, Rotigotine may decrease the antihypertensive activities of Hydrochlorothiazide.]
[R05DA03, hydrocodone, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[C03AA02, hydroflumethiazide, Rotigotine may decrease the antihypertensive activities of Hydroflumethiazide.]
[G04BD06, propiverine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[P01BA02, hydroxychloroquine, The metabolism of Rotigotine can be decreased when combined with Hydroxychloroquine.]
[N05AX07, prothipendyl, Prothipendyl may increase the sedative activities of Rotigotine.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.]
[C02AC06, rilmenidine, Rotigotine may decrease the antihypertensive activities of Rilmenidine.]
[R02AX02, ibuprofen, The risk or severity of hypertension can be increased when Ibuprofen is combined with Rotigotine.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Rotigotine.]
[N01AH03, sufentanil, Sufentanil may increase the sedative activities of Rotigotine.]
[N06AA02, imipramine, Imipramine may increase the sedative activities of Rotigotine.]
[L01CD01, paclitaxel, The risk or severity of adverse effects can be increased when Paclitaxel is combined with Rotigotine.]
[M03BX02, tizanidine, Tizanidine may increase the sedative activities of Rotigotine.]
[C03BA11, indapamide, Rotigotine may decrease the antihypertensive activities of Indapamide.]
[S01BC01, indomethacin, The risk or severity of hypertension can be increased when Indomethacin is combined with Rotigotine.]
[C02CA02, indoramin, Rotigotine may decrease the antihypertensive activities of Indoramin.]
[N06AX17, milnacipran, Milnacipran may increase the sedative activities of Rotigotine.]
[A03AA30, piperidolate, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[N01BB08, articaine, Articaine may increase the sedative activities of Rotigotine.]
[N05BA12, alprazolam, Alprazolam may increase the sedative activities of Rotigotine.]
[N05CH02, ramelteon, Ramelteon may increase the sedative activities of Rotigotine.]
[R06AE01, buclizine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[C10AA06, cerivastatin, The metabolism of Rotigotine can be decreased when combined with Cerivastatin.]
[C07AA01, alprenolol, Alprenolol may increase the sedative activities of Rotigotine.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Rotigotine.]
[N06AA13, iprindole, Iprindole may increase the sedative activities of Rotigotine.]
[N06AF05, iproniazid, Iproniazid may increase the sedative activities of Rotigotine.]
[N05AA07, chlorproethazine, Chlorproethazine may increase the sedative activities of Rotigotine.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the sedative activities of Rotigotine.]
[R03CC06, isoetharine, The risk or severity of hypertension can be increased when Isoetharine is combined with Rotigotine.]
[C09AA16, imidapril, Rotigotine may decrease the antihypertensive activities of Imidapril.]
[N01AB06, isoflurane, Isoflurane may increase the sedative activities of Rotigotine.]
[N04BX02, entacapone, Entacapone may increase the sedative activities of Rotigotine.]
[J04AC01, isoniazid, The metabolism of Rotigotine can be decreased when combined with Isoniazid.]
[R03CB01, isoproterenol, The risk or severity of hypertension can be increased when Isoprenaline is combined with Rotigotine.]
[C01DA14, isosorbide mononitrate, The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Rotigotine.]
[C05AE02, isosorbide dinitrate, The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Rotigotine.]
[C04AA01, isoxsuprine, The risk or severity of hypertension can be increased when Rotigotine is combined with Isoxsuprine.]
[N06AX18, reboxetine, Reboxetine may increase the sedative activities of Rotigotine.]
[L04AC07, tocilizumab, The metabolism of Rotigotine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Ketamine may increase the sedative activities of Rotigotine.]
[C02KD01, ketanserin, Ketanserin may increase the sedative activities of Rotigotine.]
[J02AB02, ketoconazole, The metabolism of Rotigotine can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Rotigotine can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, Olanzapine may increase the sedative activities of Rotigotine.]
[M02AA10, ketoprofen, The risk or severity of hypertension can be increased when Ketoprofen is combined with Rotigotine.]
[L04AA24, abatacept, The metabolism of Rotigotine can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The risk or severity of hypertension can be increased when Arbutamine is combined with Rotigotine.]
[N07XX04, sodium oxybate, Sodium oxybate may increase the sedative activities of Rotigotine.]
[M01AG01, mefenamic acid, The risk or severity of hypertension can be increased when Mefenamic acid is combined with Rotigotine.]
[C07AG01, labetalol, The metabolism of Rotigotine can be decreased when combined with Labetalol.]
[N04BB01, amantadine, The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Rotigotine.]
[C02AA05, deserpidine, Rotigotine may decrease the antihypertensive activities of Deserpidine.]
[N03AX18, lacosamide, Lacosamide may increase the sedative activities of Rotigotine.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Rotigotine is combined with Levodopa.]
[S02DA01, lidocaine, Lidocaine may increase the sedative activities of Rotigotine.]
[C03DB01, amiloride, The risk or severity of adverse effects can be increased when Amiloride is combined with Rotigotine.]
[N02CA07, lisuride, Lisuride may increase the sedative activities of Rotigotine.]
[N06AA07, lofepramine, Lofepramine may increase the sedative activities of Rotigotine.]
[N05BA06, lorazepam, Lorazepam may increase the sedative activities of Rotigotine.]
[C10AA02, lovastatin, The metabolism of Rotigotine can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, Loxapine may increase the sedative activities of Rotigotine.]
[L01EG01, temsirolimus, The metabolism of Rotigotine can be decreased when combined with Temsirolimus.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Rotigotine can be increased when used in combination with Magnesium sulfate.]
[L01EA03, nilotinib, The metabolism of Rotigotine can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The risk or severity of adverse effects can be increased when Mannitol is combined with Rotigotine.]
[N06AA21, maprotiline, Maprotiline may increase the sedative activities of Rotigotine.]
[A08AA05, mazindol, Mazindol may increase the sedative activities of Rotigotine.]
[C02BB01, mecamylamine, Rotigotine may decrease the antihypertensive activities of Mecamylamine.]
[R06AE05, meclizine, Meclizine may increase the sedative activities of Rotigotine.]
[M02AA18, meclofenamic acid, The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Rotigotine.]
[N05BA03, medazepam, Medazepam may increase the sedative activities of Rotigotine.]
[N05CH01, melatonin, Melatonin may increase the sedative activities of Rotigotine.]
[N02AB02, meperidine, Meperidine may increase the sedative activities of Rotigotine.]
[C01CA11, mephentermine, The risk or severity of serotonin syndrome can be increased when Mephentermine is combined with Rotigotine.]
[N03AB04, mephenytoin, Mephenytoin may increase the sedative activities of Rotigotine.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the sedative activities of Rotigotine.]
[N01BB03, mepivacaine, Mepivacaine may increase the sedative activities of Rotigotine.]
[N05BC01, meprobamate, Meprobamate may increase the sedative activities of Rotigotine.]
[N02AX05, meptazinol, Meptazinol may increase the sedative activities of Rotigotine.]
[N05AC03, mesoridazine, Mesoridazine may increase the sedative activities of Rotigotine.]
[N05AX13, paliperidone, Paliperidone may increase the sedative activities of Rotigotine.]
[C01CA09, metaraminol, The risk or severity of hypertension can be increased when Metaraminol is combined with Rotigotine.]
[A04AA04, dolasetron, Dolasetron may increase the sedative activities of Rotigotine.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Rotigotine.]
[N06BA03, methamphetamine, Metamfetamine may increase the sedative activities of Rotigotine.]
[A03AB07, methantheline, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, Methapyrilene may increase the sedative activities of Rotigotine.]
[N05CM01, methaqualone, Methaqualone may increase the sedative activities of Rotigotine.]
[N03AA30, metharbital, Metharbital may increase the sedative activities of Rotigotine.]
[S01EC05, methazolamide, The risk or severity of adverse effects can be increased when Methazolamide is combined with Rotigotine.]
[G02CB05, metergoline, Metergoline may increase the sedative activities of Rotigotine.]
[H03BB02, methimazole, The metabolism of Rotigotine can be decreased when combined with Methimazole.]
[M03BA03, methocarbamol, Methocarbamol may increase the sedative activities of Rotigotine.]
[N05CA15, methohexital, Methohexital may increase the sedative activities of Rotigotine.]
[N02BG08, ziconotide, Ziconotide may increase the sedative activities of Rotigotine.]
[N05AA02, methotrimeprazine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[C01CA10, methoxamine, The risk or severity of hypertension can be increased when Methoxamine is combined with Rotigotine.]
[N02BG09, methoxyflurane, Methoxyflurane may increase the sedative activities of Rotigotine.]
[C03AA08, methyclothiazide, The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Rotigotine.]
[C02AB01, methyldopa, Rotigotine may decrease the antihypertensive activities of Methyldopa.]
[V04CG05, methylene blue, Rotigotine may increase the serotonergic activities of Methylene blue.]
[G02AB01, methylergonovine, Methylergometrine may increase the vasoconstricting activities of Rotigotine.]
[N06BA04, methylphenidate, The risk or severity of adverse effects can be increased when Methylphenidate is combined with Rotigotine.]
[N03AF03, rufinamide, Rufinamide may increase the sedative activities of Rotigotine.]
[N05CE02, methyprylon, Methyprylon may increase the sedative activities of Rotigotine.]
[N02CA04, methysergide, Methysergide may increase the sedative activities of Rotigotine.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Rotigotine.]
[C03BA08, metolazone, Rotigotine may decrease the antihypertensive activities of Metolazone.]
[C07AB02, metoprolol, The metabolism of Rotigotine can be decreased when combined with Metoprolol.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Rotigotine.]
[N06AX03, mianserin, Mianserin may increase the sedative activities of Rotigotine.]
[S02AA13, miconazole, The metabolism of Rotigotine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Rotigotine.]
[N05CD08, midazolam, Midazolam may increase the sedative activities of Rotigotine.]
[C01CA17, midodrine, The risk or severity of hypertension can be increased when Midodrine is combined with Rotigotine.]
[G03XB01, mifepristone, The metabolism of Rotigotine can be decreased when combined with Mifepristone.]
[C09CA03, valsartan, Rotigotine may decrease the antihypertensive activities of Valsartan.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.]
[D11AX01, minoxidil, Rotigotine may decrease the antihypertensive activities of Minoxidil.]
[L01XX23, mitotane, The metabolism of Rotigotine can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, The metabolism of Lisdexamfetamine can be decreased when combined with Rotigotine.]
[N05AE02, molindone, Molindone may increase the sedative activities of Rotigotine.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Rotigotine.]
[C01BD01, amiodarone, The metabolism of Rotigotine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Rotigotine.]
[N02AA01, morphine, Morphine may increase the sedative activities of Rotigotine.]
[A04AA05, palonosetron, Palonosetron may increase the sedative activities of Rotigotine.]
[L04AB05, certolizumab pegol, The metabolism of Rotigotine can be increased when combined with Certolizumab pegol.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Rotigotine.]
[M03AC03, vecuronium, Vecuronium may increase the sedative activities of Rotigotine.]
[N05CA02, amobarbital, Amobarbital may increase the sedative activities of Rotigotine.]
[N06AA17, amoxapine, Amoxapine may increase the sedative activities of Rotigotine.]
[N03AB05, fosphenytoin, Fosphenytoin may increase the sedative activities of Rotigotine.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Rotigotine.]
[N04BC04, ropinirole, Rotigotine may increase the sedative activities of Ropinirole.]
[C04AX21, nafronyl, Naftidrofuryl may increase the sedative activities of Rotigotine.]
[N02AF02, nalbuphine, Nalbuphine may increase the sedative activities of Rotigotine.]
[V03AB15, naloxone, The metabolism of Rotigotine can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Rotigotine.]
[L04AC03, anakinra, The metabolism of Rotigotine can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The risk or severity of hypertension can be increased when Rotigotine is combined with Naphazoline.]
[N06BA01, amphetamine, The metabolism of Amphetamine can be decreased when combined with Rotigotine.]
[M02AA12, naproxen, The risk or severity of hypertension can be increased when Naproxen is combined with Rotigotine.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Rotigotine is combined with Duloxetine.]
[N04BX01, tolcapone, Tolcapone may increase the sedative activities of Rotigotine.]
[N01AH06, remifentanil, Remifentanil may increase the sedative activities of Rotigotine.]
[C01CX08, levosimendan, The risk or severity of adverse effects can be increased when Levosimendan is combined with Rotigotine.]
[N05AX14, iloperidone, Iloperidone may increase the sedative activities of Rotigotine.]
[J02AA01, amphotericin B, The risk or severity of adverse effects can be increased when Amphotericin B is combined with Rotigotine.]
[N06AX23, desvenlafaxine, Desvenlafaxine may increase the sedative activities of Rotigotine.]
[C09CA07, telmisartan, Rotigotine may decrease the antihypertensive activities of Telmisartan.]
[C10AD02, niacin, The metabolism of Rotigotine can be decreased when combined with Niacin.]
[N06AF02, nialamide, Nialamide may increase the sedative activities of Rotigotine.]
[C08CA04, nicardipine, The metabolism of Rotigotine can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, Nicergoline may increase the vasoconstricting activities of Rotigotine.]
[C08CA05, nifedipine, The metabolism of Rotigotine can be decreased when combined with Nifedipine.]
[M02AA17, niflumic acid, The risk or severity of hypertension can be increased when Niflumic acid is combined with Rotigotine.]
[V03AB22, amyl nitrite, The risk or severity of adverse effects can be increased when Amyl Nitrite is combined with Rotigotine.]
[C08CA06, nimodipine, Rotigotine may decrease the antihypertensive activities of Nimodipine.]
[C08CA07, nisoldipine, Rotigotine may decrease the antihypertensive activities of Nisoldipine.]
[N05CD02, nitrazepam, Nitrazepam may increase the sedative activities of Rotigotine.]
[C08CA08, nitrendipine, Rotigotine may decrease the antihypertensive activities of Nitrendipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Rotigotine.]
[N05CF03, zaleplon, Zaleplon may increase the sedative activities of Rotigotine.]
[N04BC05, pramipexole, Rotigotine may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, Rotigotine may decrease the antihypertensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, Nitrous oxide may increase the sedative activities of Rotigotine.]
[N06AX04, nomifensine, Nomifensine may increase the sedative activities of Rotigotine.]
[C01CA03, norepinephrine, The risk or severity of hypertension can be increased when Norepinephrine is combined with Rotigotine.]
[C02KX01, bosentan, Rotigotine may decrease the antihypertensive activities of Bosentan.]
[N06AA10, nortriptyline, Nortriptyline may increase the sedative activities of Rotigotine.]
[G02CA02, nylidrin, The risk or severity of hypertension can be increased when Rotigotine is combined with Nylidrin.]
[L04AC04, rilonacept, The metabolism of Rotigotine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Rotigotine can be decreased when combined with Omeprazole.]
[N06AA05, opipramol, Opipramol may increase the sedative activities of Rotigotine.]
[N02AA02, opium, Opium may increase the sedative activities of Rotigotine.]
[R03CB03, metaproterenol, The risk or severity of hypertension can be increased when Orciprenaline is combined with Rotigotine.]
[G02CB04, quinagolide, The risk or severity of adverse effects can be decreased when Rotigotine is combined with Quinagolide.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Rotigotine.]
[P02BA02, oxamniquine, The metabolism of Rotigotine can be decreased when combined with Oxamniquine.]
[N05BA04, oxazepam, Oxazepam may increase the sedative activities of Rotigotine.]
[C07AA02, oxprenolol, Oxprenolol may increase the sedative activities of Rotigotine.]
[N02AA05, oxycodone, Oxycodone may increase the sedative activities of Rotigotine.]
[C01DX03, oxyfedrine, The risk or severity of hypertension can be increased when Rotigotine is combined with Oxyfedrine.]
[S01GA04, oxymetazoline, The risk or severity of hypertension can be increased when Oxymetazoline is combined with Rotigotine.]
[N02AA11, oxymorphone, Oxymorphone may increase the sedative activities of Rotigotine.]
[N05AE01, oxypertine, Oxypertine may increase the sedative activities of Rotigotine.]
[S01BC02, oxyphenbutazone, The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Rotigotine.]
[A03AB03, oxyphenonium, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[N05AH05, asenapine, Asenapine may increase the sedative activities of Rotigotine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.]
[M03AC01, pancuronium, Pancuronium may increase the sedative activities of Rotigotine.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Papaverine is combined with Rotigotine.]
[N05CC05, paraldehyde, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[C02KC01, pargyline, Pargyline may increase the sedative activities of Rotigotine.]
[G04BD11, fesoterodine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, Penbutolol may increase the sedative activities of Rotigotine.]
[N05AG03, penfluridol, Penfluridol may increase the sedative activities of Rotigotine.]
[N02AD01, pentazocine, Pentazocine may increase the sedative activities of Rotigotine.]
[N05CA01, pentobarbital, Pentobarbital may increase the sedative activities of Rotigotine.]
[N05AB10, perazine, Perazine may increase the sedative activities of Rotigotine.]
[N04BC02, pergolide, Pergolide may increase the sedative activities of Rotigotine.]
[C08EX02, perhexiline, The metabolism of Rotigotine can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, Perphenazine may increase the sedative activities of Rotigotine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Rotigotine.]
[N02AD02, phenazocine, Phenazocine may increase the sedative activities of Rotigotine.]
[N06AF03, phenelzine, Phenelzine may increase the sedative activities of Rotigotine.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Rotigotine.]
[B01AA02, phenindione, The risk or severity of adverse effects can be increased when Rotigotine is combined with Phenindione.]
[N03AA02, phenobarbital, Phenobarbital may increase the sedative activities of Rotigotine.]
[N01AH04, phenoperidine, Phenoperidine may increase the sedative activities of Rotigotine.]
[C04AX02, phenoxybenzamine, Rotigotine may decrease the antihypertensive activities of Phenoxybenzamine.]
[B01AA04, phenprocoumon, The risk or severity of adverse effects can be increased when Rotigotine is combined with Phenprocoumon.]
[A08AA01, phentermine, The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Rotigotine.]
[V03AB36, phentolamine, Rotigotine may decrease the antihypertensive activities of Phentolamine.]
[M02AA01, phenylbutazone, The risk or severity of hypertension can be increased when Phenylbutazone is combined with Rotigotine.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be increased when Phenylephrine is combined with Rotigotine.]
[R01BA01, phenylpropanolamine, The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Rotigotine.]
[N03AB02, phenytoin, Phenytoin may increase the sedative activities of Rotigotine.]
[L04AB06, golimumab, The metabolism of Rotigotine can be increased when combined with Golimumab.]
[C08CX01, mibefradil, The metabolism of Rotigotine can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, Pimozide may increase the sedative activities of Rotigotine.]
[C07AA03, pindolol, Pindolol may increase the sedative activities of Rotigotine.]
[J05AE01, saquinavir, The metabolism of Rotigotine can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Rotigotine.]
[N05AC04, pipothiazine, Pipotiazine may increase the sedative activities of Rotigotine.]
[C09CA02, eprosartan, Rotigotine may decrease the antihypertensive activities of Eprosartan.]
[A02BX03, pirenzepine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N04BC08, piribedil, The risk or severity of adverse effects can be decreased when Rotigotine is combined with Piribedil.]
[N02AC03, pirinitramide, Piritramide may increase the sedative activities of Rotigotine.]
[S01BC06, piroxicam, The risk or severity of hypertension can be increased when Piroxicam is combined with Rotigotine.]
[N02CX01, pizotyline, Pizotifen may increase the sedative activities of Rotigotine.]
[J05AG02, delavirdine, The metabolism of Rotigotine can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, Rotigotine may decrease the antihypertensive activities of Irbesartan.]
[N05CA22, proxibarbal, Proxibarbal may increase the sedative activities of Rotigotine.]
[A03AE01, alosetron, Alosetron may increase the sedative activities of Rotigotine.]
[L04AC08, canakinumab, The metabolism of Rotigotine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Rotigotine may decrease the antihypertensive activities of Polythiazide.]
[J05AE03, ritonavir, The serum concentration of Rotigotine can be increased when it is combined with Ritonavir.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Rotigotine.]
[N05BA11, prazepam, Prazepam may increase the sedative activities of Rotigotine.]
[C02CA01, prazosin, Rotigotine may decrease the antihypertensive activities of Prazosin.]
[N01BB04, prilocaine, Prilocaine may increase the sedative activities of Rotigotine.]
[P01BA03, primaquine, The metabolism of Rotigotine can be decreased when combined with Primaquine.]
[N03AA03, primidone, Primidone may increase the sedative activities of Rotigotine.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Rotigotine.]
[S01HA05, procaine, Procaine may increase the sedative activities of Rotigotine.]
[L01XB01, procarbazine, Procarbazine may increase the sedative activities of Rotigotine.]
[N05AB04, prochlorperazine, Prochlorperazine may increase the sedative activities of Rotigotine.]
[N04AA04, procyclidine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[G03DA04, progesterone, The metabolism of Progesterone can be decreased when combined with Rotigotine.]
[N05AA03, promazine, Promazine may increase the sedative activities of Rotigotine.]
[R06AD02, promethazine, Promethazine may increase the sedative activities of Rotigotine.]
[C01BC03, propafenone, The metabolism of Rotigotine can be decreased when combined with Propafenone.]
[N01AX04, propanidid, Propanidid may increase the sedative activities of Rotigotine.]
[A03AB05, propantheline, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, Periciazine may increase the sedative activities of Rotigotine.]
[N05CM06, propiomazine, Propiomazine may increase the sedative activities of Rotigotine.]
[N01AX10, propofol, Propofol may increase the sedative activities of Rotigotine.]
[N02AC04, propoxyphene, Dextropropoxyphene may increase the sedative activities of Rotigotine.]
[C07AA05, propranolol, The metabolism of Propranolol can be decreased when combined with Rotigotine.]
[N02CC04, rizatriptan, Rizatriptan may increase the sedative activities of Rotigotine.]
[B01AC09, epoprostenol, Rotigotine may decrease the antihypertensive activities of Epoprostenol.]
[N06AA11, protriptyline, Protriptyline may increase the sedative activities of Rotigotine.]
[R01BA02, pseudoephedrine, The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Rotigotine.]
[N05AX12, aripiprazole, Aripiprazole may increase the sedative activities of Rotigotine.]
[A03AB15, diphemanil, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, Talbutal may increase the sedative activities of Rotigotine.]
[N05CA09, vinbarbital, Vinbarbital may increase the sedative activities of Rotigotine.]
[N05BB02, captodiamine, Captodiame may increase the sedative activities of Rotigotine.]
[M03BA04, styramate, Styramate may increase the sedative activities of Rotigotine.]
[P02CC01, pyrantel, Pyrantel may increase the sedative activities of Rotigotine.]
[R06AC01, pyrilamine, Mepyramine may increase the sedative activities of Rotigotine.]
[C01BA01, quinidine, The metabolism of Rotigotine can be decreased when combined with Quinidine.]
[P01BC01, quinine, Quinine may increase the sedative activities of Rotigotine.]
[A02BA02, ranitidine, The metabolism of Rotigotine can be decreased when combined with Ranitidine.]
[C02AA01, rescinnamine, Rotigotine may decrease the antihypertensive activities of Rescinnamine.]
[C02AA02, reserpine, Reserpine may increase the sedative activities of Rotigotine.]
[J04AB02, rifampin, The metabolism of Rotigotine can be increased when combined with Rifampicin.]
[R03AC05, rimiterol, The risk or severity of hypertension can be increased when Rotigotine is combined with Rimiterol.]
[G02CA01, ritodrine, The risk or severity of hypertension can be increased when Ritodrine is combined with Rotigotine.]
[N06AX01, 5-hydroxytryptophan, Oxitriptan may increase the sedative activities of Rotigotine.]
[N02BA05, salicylamide, The risk or severity of hypertension can be increased when Rotigotine is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of hypertension can be increased when Sulfasalazine is combined with Rotigotine.]
[S01BC08, salicylic acid, The risk or severity of hypertension can be increased when Salicylic acid is combined with Rotigotine.]
[S01FA02, scopolamine, Scopolamine may increase the sedative activities of Rotigotine.]
[N05CA06, secobarbital, Secobarbital may increase the sedative activities of Rotigotine.]
[N04BD01, selegiline, Selegiline may increase the sedative activities of Rotigotine.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Rotigotine is combined with Obinutuzumab.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Rotigotine.]
[C03DA01, spironolactone, The risk or severity of adverse effects can be increased when Spironolactone is combined with Rotigotine.]
[M01AE11, tiaprofenic acid, The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Rotigotine.]
[C03CC01, ethacrynic acid, The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Rotigotine.]
[R03BB01, ipratropium bromide, Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
